• Vetiranary Medicine
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

AVMA clarifies report's context on lethal injection

March 1, 2006
Jennifer Fiala

Schaumburg, Ill. ? The American Veterinary Medical Association (AVMA) wants capital punishment opponents to stop quoting its euthanasia guidelines to contest lethal injection.

SCHAUMBURG, ILL. — The American Veterinary Medical Association (AVMA) wants capital punishment opponents to stop quoting its euthanasia guidelines to contest lethal injection.

At presstime, the group approved a landing letter highlighting "misinterpretations" to its 2000 Report of the AVMA Panel on Euthanasia, which has bolstered death penalty appeals from Kentucky to Texas. Capital punishment opponents use the guidelines as a legal tactic to challenge use of pancuronium bromide, one ingredient in the three-drug cocktail of most lethal injections. AVMA deems the muscle relaxant so cruel, the group advises against using it on animals, prisoner advocates say, adding that a slight dosage error could cause inmates to suffocate before losing consciousness and paralyze them while dying.

For the record

Advertisement

But AVMA's stance on the drug has been misinterpreted, group leaders say. The group's 27-page euthanasia report fails to mention pancuronium bromide, which paralyzes skeletal muscles but not the brain or nerves. Under the heading "pentobarbital combinations," AVMA notes, "A combination of pentobarbital with a neuromuscular blocking agent is not an acceptable euthanasia agent."

Capital punishment opponents and the media have wrongly used this statement and others to infer that AVMA deems the drug's use for euthanasia inhumane, says Dr. Elizabeth Sabin, assistant director of the AVMA Education and Research Division.

"The panel's objective in developing these guidelines was to give veterinarians guidance in relieving pain and suffering of animals that are to be euthanized," she says. "The report should not be extrapolated to humans."

Line by line

To further clarify the guidelines, AVMA outlines the report's segments that have been misinterpreted most:

1. Agents that induce death by direct or indirect hypoxia can act at various sites and can cause loss of consciousness at different rates. For death to be painless and distress-free, loss of consciousness should precede loss of motor activity. Loss of motor activity, however, cannot be equated with loss of consciousness and absence of distress. Thus, agents that induce muscle paralysis without loss of consciousness are not acceptable as sole agents for euthanasia (e.g., depolarizing and non-depolarizing muscle relaxants, strychnine, nicotine and magnesium slats). With other techniques that induce hypoxia, some animals may have motor activity following loss of consciousness, but this is reflex activity and is not perceived by the animal.

2. Pentobarbital combinations: Several euthanasia products are formulated to include a barbituric acid derivative, usually sodium pentobarbital. Although some of these additives are slowly cardio toxic, this pharmacologic effect is inconsequential. These combination products are listed by the (Drug Enforcement Agency) as Schedule III drugs, making them somewhat simpler to obtain, store and administer than Schedule II drugs such as sodium pentobarbital. The pharmacologic properties and recommended use of combination products that combine sodium pentobarbital with lidocaine or phenytoin are interchangeable with those of pure barbituric acid derivatives.

The first section of text indicates that neuromuscular blocking agents should not be the sole method of euthanasia. The second section refers to mixing a barbiturate and neuromuscular blocking agent in the same syringe, which might allow the animal to become paralyzed while conscious. Both actions do not happen during human lethal injections, AVMA says.

"When referring to the 2000 Report of the AVMA Panel on Euthanasia, reporters are strongly encouraged to contact the AVMA to ensure the association's position is stated correctly," AVMA officials add.

Related Content:

Association
ABVS approves full recognition for shelter medicine practice
ABVS approves full recognition for shelter medicine practice
Pet Advocacy Network honors outstanding contributions to the pet care community
Pet Advocacy Network honors outstanding contributions to the pet care community
Q&A with AVMA treasurer Dr Arnold L. Goldman
Q&A with AVMA treasurer Dr Arnold L. Goldman

Advertisement

Latest News

Spectrum of care: protocols to support pet owners’ budgets

How to support women while still running a successful business

The Vets expands to Raleigh, NC

Two pups find their forever homes while at Fetch Charlotte

View More Latest News
Advertisement